|
ZDHHC7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.44399999735256E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12679999997312E-07 |
| Normal-vs-Stage2 |
6.135700E-03 |
| Normal-vs-Stage3 |
4.65299999641289E-08 |
| Normal-vs-Stage4 |
3.33060000023977E-07 |
| Stage1-vs-Stage2 |
1.985440E-01 |
| Stage1-vs-Stage3 |
2.086600E-01 |
| Stage1-vs-Stage4 |
1.852370E-01 |
| Stage2-vs-Stage3 |
5.470400E-02 |
| Stage2-vs-Stage4 |
4.074200E-02 |
| Stage3-vs-Stage4 |
7.620000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37380000100984E-08 |
| Normal-vs-AfricanAmerican |
1.378450E-03 |
| Normal-vs-Asian |
3.794000E-04 |
| Caucasian-vs-AfricanAmerican |
4.492200E-01 |
| Caucasian-vs-Asian |
5.117400E-01 |
| AfricanAmerican-vs-Asian |
9.501000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01269999999809E-05 |
| Normal-vs-Female |
1.09900000211383E-08 |
| Male-vs-Female |
4.841000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.55990000003403E-06 |
| Normal-vs-Age(41-60Yrs) |
5.32420000309841E-08 |
| Normal-vs-Age(61-80Yrs) |
4.29290000003579E-06 |
| Normal-vs-Age(81-100Yrs) |
1.917200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.711000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.351000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.953000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.899800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.744800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.294000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.550200E-02 |
| Classical-VS-Follicular |
4.184200E-01 |
| Classical-VS-Other |
1.984840E-01 |
| Classical-VS-Normal |
4.37119999996405E-06 |
| Tall-VS-Follicular |
2.077600E-01 |
| Tall-VS-Other |
7.388400E-01 |
| Tall-VS-Normal |
4.05700000039033E-07 |
| Follicular-VS-Other |
4.304400E-01 |
| Follicular-VS-Normal |
2.12729999999883E-05 |
| Other-VS-Normal |
1.982770E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12060000004399E-07 |
| Normal-vs-N1 |
1.56880000101722E-08 |
| N0-vs-N1 |
2.092200E-02 |
|
|
